Showing results (231-240 of 496) with videos related to

Sort By:
Pageof 50
Clinical Pharmacology and Therapeutics|May 28, 2021
Assessing the Impact of US Food and Drug Administration Breakthrough Therapy Designation Timing on Trial Characteristics and Development SpeedLisette Pregelj, Damian C Hine, Aaron S Kesselheim, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|July 27, 2022
High-Priced Sickle Cell Gene Therapies Threaten to Exacerbate US Health Disparities and Establish New Pricing Precedents for Molecular MedicineFrazer A Tessema, Ameet Sarpatwari, Leah Z Rand, et al.
JAMA|April 7, 2024
Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated ApprovalIan T T Liu, Aaron S Kesselheim, Edward R Scheffer Cliff
Annals of Internal Medicine|October 1, 2019
Variation in Prescription Drug Prices by Retail Pharmacy Type: A National Cross-sectional StudyJing Luo, Martin Kulldorff, Ameet Sarpatwari, et al.
JAMA Pediatrics|November 20, 2018
Completion Rate and Reporting of Mandatory Pediatric Postmarketing Studies Under the US Pediatric Research Equity ActThomas J Hwang, Liat Orenstein, Aaron S Kesselheim, et al.
JAMA Network Open|August 31, 2019
Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs: A Systematic Review and Pooled AnalysisBishal Gyawali, Frazer A Tessema, Emily H Jung, et al.
JAMA|September 24, 2014
Electronic medication packaging devices and medication adherence: a systematic reviewKyle D Checchi, Krista F Huybrechts, Jerry Avorn, et al.
Health Affairs (Project Hope)|May 17, 2022
Patents And Regulatory Exclusivities On Inhalers For Asthma And COPD, 1986-2020William B Feldman, Doni Bloomfield, Reed F Beall, et al.
JAMA Network Open|April 13, 2019
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysisElvira D'Andrea, Spencer P Hey, Cherie L Ramirez, et al.
Neurology|July 12, 2023
Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine MedicationsLeigh K Sharpless, Aaron S Kesselheim, Serena L Orr, et al.
Pageof 50